Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-300 as a combination therapy for non or never-smokers with non-small cell lung cancer adenocarcinoma. In addition, its preclinical development drug candidate is LP-184, an alkylating agent that damages DNA in cancer cells that overexpress certain biomarkers or that harbor mutations in DNA repair pathways. Further, the company operates ADC program, an antibody drug conjugate therapeutic approach for cancer treatment. Additionally, the company's artificial intelligence platform RADR uses big data analytics and machine learning for combining molecular data. The company was incorporated in 2013 and is headquartered in Dallas, Texas. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Lantern Pharma Inc..
Lantern Pharma Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Lantern Pharma Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Lantern Pharma Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Lantern Pharma Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Lantern Pharma Inc. and all latest updates of the company are provided.
The 2025 version of Lantern Pharma Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Lantern Pharma Inc.- Key Facts
2.2 Lantern Pharma Inc.- Geographic Locations
2.3 Lantern Pharma Inc.- Subsidiaries and Affiliates
2.4 Lantern Pharma Inc.- Business Divisions
2.5 Lantern Pharma Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Lantern Pharma Inc. Strategic Analysis Review
3.1 Lantern Pharma Inc.- Key Strategies
3.2 Lantern Pharma Inc.- Company Outlook Statement
3.3 Lantern Pharma Inc.- SWOT Analysis
3.3.1 Lantern Pharma Inc.- Key Strengths
3.3.2 Lantern Pharma Inc.- Key Weaknesses
3.3.3 Lantern Pharma Inc.- Potential Opportunities
3.3.4 Lantern Pharma Inc.- Potential Threats
3.4 Lantern Pharma Inc.- Key Competitors
4. Business Description of the Company
4.1 Lantern Pharma Inc.- Business Overview
4.2 Lantern Pharma Inc.- Operations by Segment
5 Products and Services Details
5.1 Lantern Pharma Inc.- Key Products
5.2 Lantern Pharma Inc.- Key Service Areas
5.3 Lantern Pharma Inc.- Key Brands
6 Company Developments
6.1 Lantern Pharma Inc.- Company History
6.2 Lantern Pharma Inc.- Latest Developments
7 Financial Analysis
7.1 Lantern Pharma Inc.- Income Statements
7.2 Lantern Pharma Inc.- Balance Sheet
7.3 Lantern Pharma Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Lantern Pharma Inc.- Direct Competitors
8.2 Lantern Pharma Inc.- Competitor Financial Ratios comparison
8.3 Lantern Pharma Inc.- Competitor Stock Charts Comparison
8.4 Lantern Pharma Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!